您的购物车当前为空
别名 GS-9688
Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection.


为众多的药物研发团队赋能,
让新药发现更简单!
Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | 待询 | 5日内发货 | |
| 25 mg | ¥ 35,400 | 6-8周 | |
| 50 mg | ¥ 46,300 | 6-8周 | |
| 100 mg | ¥ 55,400 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 21,500 | 5日内发货 |
| 产品描述 | Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection. |
| 体外活性 | Selgantolimod induces the cellular immune mediators interleukin (IL)-12 and IL-8, as well as the antiviral cytokines tumor necrosis factor-α and interferon-γ in vitro in human peripheral blood mononuclear cells. Selgantolimod-induced cytokines reduce HBV DNA, RNA, and antigen levels in HBV-infected primary human hepatocytes. Selgantolimod activates natural killer and mucosal-associated invariant T cells, stimulates cluster of differentiation (CD)-8+ T-cell proliferation, and increase IFNγ production while lowering programmed cell death protein 1 expression by HBV-specific CD8+-T cells in vitro in peripheral blood mononuclear cells [1]. |
| 体内活性 | Selgantolimod (p.o., once-weekly) treatment induces dose-dependent increases in serum IL-12 and IL-1 receptor antagonist (IL-1RA) in cynomolgus monkeys and causes functional cure in the woodchuck model of chronic HBV [1]. |
| 别名 | GS-9688 |
| 分子量 | 293.34 |
| 分子式 | C14H20FN5O |
| CAS No. | 2004677-13-6 |
| Smiles | CCCC[C@](C)(CO)Nc1nc(N)nc2cc(F)cnc12 |
| 密度 | 1.299 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多